Clinical Trials · NCT03350191
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 13
- Start date
- Dec 2017
- Locations
- 1 site, Sweden
- Primary endpoint
- Glucagon receptor occupancy